Literature DB >> 12355385

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

Raymund R Razonable1, Kelly W Burak, Hester van Cruijsen, Robert A Brown, Michael R Charlton, Thomas F Smith, Mark J Espy, Walter Kremers, Jennie A Wilson, Cynthia Groettum, Russell Wiesner, Carlos V Paya.   

Abstract

We investigated the effect of beta-herpesviruses on allograft failure and mortality, hepatitis C virus (HCV) replication, and liver histologic characteristics among 92 HCV-infected liver transplant recipients. Reactivation of cytomegalovirus (CMV) but not of human herpesvirus 6 (HHV-6) was independently associated with allograft failure and mortality (risk ratio, 3.71; 95% confidence interval, 1.64-8.39); allograft failure and mortality was observed in 48% of patients with CMV disease, 35% of patients with subclinical CMV infection, and 17% of patients without CMV infection (P=.0275). CMV reactivation was highly predictive of mortality (P<.001), regardless of whether it remained subclinical or evolved into CMV disease. Patients with CMV disease had a higher fibrosis stage (P=.05) and had a trend toward a higher hepatitis activity index (P=.10) and HCV load (P=.10) at 16 weeks after liver transplantation. The pathogenesis of HCV is influenced by its interaction with CMV but not with HHV-6.

Entities:  

Mesh:

Year:  2002        PMID: 12355385     DOI: 10.1086/342911

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

Review 1.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

2.  Cytomegalovirus: prophylaxis, preemption, or "wait and watch".

Authors:  Shmuel Shoham
Journal:  Liver Transpl       Date:  2012-12-12       Impact factor: 5.799

Review 3.  Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management.

Authors:  Sanjay K Yadav; Sanjiv Saigal; Narendra S Choudhary; Sujit Saha; Navin Kumar; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-05-22

Review 4.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

5.  Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.

Authors:  Tracy L Lemonovich; Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

6.  Current concepts on cytomegalovirus infection after liver transplantation.

Authors:  Sang-Oh Lee; Raymund R Razonable
Journal:  World J Hepatol       Date:  2010-09-27

7.  Gastrointestinal Infections Caused by Cytomegalovirus.

Authors:  David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

Review 8.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

10.  R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.

Authors:  Robert A Brown; Jonathon H Gralewski; Albert J Eid; Bettina M Knoll; Robert W Finberg; Raymund R Razonable
Journal:  Transplantation       Date:  2010-04-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.